论文部分内容阅读
目的研究并测算出一套既能满足我国新医改要求,又能保证公立医院正常运行的药品销售加价差别差率模式。方法对全国东、中、西部7个省的公立医院药品销售数据进行抽样调查,同时结合中国药学会科技开发中心全国医药经济信息网数据库中的药品购销数据进行样本扩充,对共计463家公立医院的药品销售数据进行统计分析。结果我国公立医院实行药品差别差率模式的价格区段分界点分别为8、40、100、2 000元。结论在我国公立医院实行药品销售差别差率模式,同时结合合理的配套政策,可以保证改革中公立医院药品收入的总体水平不受影响。
Objective To study and calculate a set of differential rates of difference in sales of medicines which can meet the requirements of new medical reform in our country and ensure the normal operation of public hospitals. Methods Sampling survey was conducted on the sales data of public hospitals in the seven provinces of the eastern, central and western parts of the country. At the same time, sample data were expanded based on the purchase and sale of medicines in the database of National Pharmaceutical and Economic Information Network of the Chinese Pharmaceutical Association Science and Technology Development Center. A total of 463 public hospitals Of the drug sales data for statistical analysis. Results In China’s public hospitals, the price section of the drug difference rate model was demarcated at 8,40,100,2,000 yuan respectively. Conclusion In our country, the implementation of the drug sales differential rate model in public hospitals, combined with reasonable supporting policies, can ensure that the reform of public hospitals in the overall level of drug income is not affected.